Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy.

Walter U, Mühlenhoff C, Benecke R, Dressler D, Mix E, Alt J, Wittstock M, Dudesek A, Storch A, Kamm C.